|

LP-184 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Lantern Pharma Inc.1

Indications

  • DDR Gene Mutation1
  • TNBC - Triple-Negative Breast Cancer1
  • GBM1
  • Metastatic Solid Tumor1
  • Advanced Solid Tumor1

Springdale, Arkansas1 trial

Study of LP-184 in Patients With Advanced Solid Tumors

Highlands Oncology Group

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.